First, SMURF2 inhibition by c-SRC upregulates the TβR pathway by stabilising TGFβR complex a function we define to be critical for HGF-induced EMT and invasion in vitro and tumour progression in vivo in bladder cancer. The gene discussed is SRC; the disease is urinary bladder carcinoma.